PR Newswire BiotechOriginal article
Galmed Pharmaceuticals Becomes EoCene, Unveiling New Ticker Symbol "EOCN" to Reflect its New Dawn Platform for GI Innovation
Positive
AI Analysis
Summary
Galmed Pharmaceuticals rebranded to EoCene with new ticker symbol EOCN to reflect its New Dawn Platform for GI innovation. The company terminated its Standby Equity Purchase Agreement with Yorkville and regained compliance with Nasdaq minimum bid price requirements.
Outcome Details
Company rebranded to EoCene with new ticker symbol EOCN; Standby Equity Purchase Agreement with Yorkville terminated; company regained Nasdaq compliance with minimum bid price requirement
Importance:4/10
Sentiment:
0.50
rebrandingticker changeNasdaq complianceSEPA terminationequity financing
Related Companies
Read the original article
Published by PR Newswire Biotech on September 9, 2026 11:30 AM
